Kansarka sanbabada ayaa weli ah caqabad caafimaad oo caalami ah, isagoo ku jira darajada labaad ee kansarka ugu badan ee la ogaado. Sannadkii 2020 oo keliya, waxaa adduunka oo dhan ka dhacay in ka badan 2.2 milyan oo kiisas cusub. Kansarka sambabada unugyada aan yarayn (NSCLC) wuxuu ka dhigan yahay in ka badan 80% dhammaan cudurrada kansarka sanbabada, taas oo muujinaysa baahida degdegga ah ee loo baahan yahay xeelado daaweyn oo la beegsado oo waxtar leh.
Isbeddellada EGFR ayaa u soo baxay sidii dhagax tiir u ah daawaynta shakhsi ahaaneed ee NSCLC. EGFR tyrosine kinase inhibitors (TKIs) waxay bixiyaan hab kacaan ah iyaga oo xannibaya calaamadaha kansarka-wadidda, joojinta koritaanka burada, iyo kor u qaadida dhimashada unugyada kansarka-dhammaan iyada oo la yareynayo dhaawaca unugyada caafimaadka qaba.
Tilmaamaha kiliinikada ee hogaaminaya, oo ay ku jiraan NCCN, hadda waxay amar ku siinayaan baaritaanka isbeddelka EGFR ka hor inta aan la bilaabin daawaynta TKI, hubinta in bukaanada saxda ah ay helaan daawooyinka saxda ah bilowga hore.
Isbeddellada EGFR ayaa u soo baxay sidii dhagax tiir u ah daawaynta shakhsi ahaaneed ee NSCLC. EGFR tyrosine kinase inhibitors (TKIs) waxay bixiyaan hab kacaan ah iyaga oo xannibaya calaamadaha kansarka-wadidda, joojinta koritaanka burada, iyo kor u qaadida dhimashada unugyada kansarka-dhammaan iyada oo la yareynayo dhaawaca unugyada caafimaadka qaba.
Tilmaamaha kiliinikada ee hogaaminaya, oo ay ku jiraan NCCN, hadda waxay amar ku siinayaan baaritaanka isbeddelka EGFR ka hor inta aan la bilaabin daawaynta TKI, hubinta in bukaanada saxda ah ay helaan daawooyinka saxda ah bilowga hore.
Soo bandhigida Bani'aadamka EGFR Gene 29 Qalabka Ogaanshaha Isbeddellada (Fluorescence PCR)
Ogaanshaha Saxda ah ee Go'aamada Daawaynta Kalsoonida leh
Qalabka ogaanshaha EGFR ee Macro & Micro-Test waxa uu awood u siinaya in si degdeg ah oo sax ah loo aqoonsado 29 isbeddellada muhiimka ah ee guud ahaan exons 18–21 ee unugyo iyo dheecaan-qaadis labadaba — awoodna u siinaya dhakhaatiirta in ay si kalsooni leh ugu diyaariyaan daawaynta.
Maxaa DoortayImtixaanka Macro & Micro-Test'sQalabka Tijaabada EGFR?
Xirmadu waxay ogaataa 29 isbeddellada hiddo-wadaha EGFR ee caadiga ah ee exons 18-21 oo laga soo qaaday unugyada ama muunadaha dhiigga ee bukaannada NSCLC, oo daboolaya dareenka daroogada iyo goobaha iska caabinta si loo hago isticmaalka dawooyinka la beegsaday sida gefitinib iyo osimertinib.
- 1.Tignoolajiyada ARMS ee la hagaajiyay: ARMS la xoojiyey oo leh xoojiye rukhsad leh oo gaar ah;
- 2.Enzymatic Enrichment: Waxay yaraynaysaa asalka duurjoogta ah ee dheef-shiid kiimikaadka enzymatic, hagaajinta saxnaanta ogaanshaha iyo yaraynta xoojinta aan gaarka ahayn sababtoo ah asalka sare ee genomic;
- 3.Xakamaynta Heerkulka: Waxay ku daraysaa wejiyada heerkulka gaarka ah ee geeddi-socodka PCR, yaraynta is-maandhaafka iyo kordhinta saxnaanta ogaanshaha;
- 4.Dareenka Sare: Wuxuu ogaadaa isbeddellada sida ugu hooseeya 1% mutation;
- 5.Great Saxnimada: Xakamaynta gudaha iyo UNG enzyme si loo yareeyo natiijooyinka beenta ah;
- 6.Wax-ku-oolnimada: Natiijooyinka ujeeddada ee 120 min gudahood
- 7.Dual Sample Support - La hagaajiyay ee unugyada iyo shaybaarada dhiigga labadaba, oo bixisa dabacsanaan xagga waxqabadka kiliinikada
- 8.Wide waafaqid: Si ballaaran ula jaan qaada qalabka PCR-ga caadiga ah ee suuqa;
- 9.Shelf-life: 12 bilood.
Daawaynta Tilmaamaha Kalsoonida
Qalabkani waxa uu caawiyaa in la kordhiyo natiijooyinka kiliinikada oo uu ka horeeyo iska caabbinta dareenka muhiimka ah iyo isbeddellada iska caabinta.
Balaadhi faylalkaaga Oncology ee saxda ah
Sahami noocyada kala duwan ee xalalka ogaanshaha isu-beddelka ee KRAS, BRAF, ROS1, ALK, BCR-ABL, TEL-AML1, iyo in ka badan-dhammaan loogu talagalay in lagu taageero daryeelka dhammaystiran ee biomarker-ka wado.
Wax badan barohttps://www.mmtest.com/oncology/
Contact our team: marketing@mmtest.com
Waqtiga boostada: Seb-23-2025